News
"The scale at which we analyzed the amyloid peptides was unprecedented," said Ben Lehner of the Wellcome Sanger Institute.
11d
Kyodo News on MSNFinal phase of trial for Parkinson's drug to treat Alzheimer's begins in JapanThe final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...
New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results ...
Hosted on MSN5mon
Which parent is more likely to pass down Alzheimer’s disease? New research has the answerAlzheimer's can be passed down from parents to children, but new research reveals whether a particular ... living in the US, Canada, Japan, and Australia. Candidates were asked if either parent ...
A readily available sleep aid has been shown to have a surprising side effect on brain health, seemingly protecting the organ ...
"There is no opportunity here anymore, and I don't want to waste my time," said a scientist who is studying Alzheimer's and moving to Germany.
Two new drugs targeting early-stage Alzheimer’s disease are expected to be put into clinical use as soon as Thursday next ...
A research team from Kanazawa University in Japan published a study in Nature ... blood flow and risk factors for brain infarction and dementia. The investigation revealed that drinking about ...
Professor Himanshu Rai gets us started on the concepts of brains, funding, and breakthroughs in Japan’s master plan for ...
9d
News-Medical.Net on MSNIntegrating discoveries with translational science to transform Alzheimer's careAt the 12th annual Helen and Robert Appel Alzheimer's Disease Research Institute Symposium, scientists and clinicians shared ...
A US study shows that many research participants don’t want to know their risks of getting Alzheimer’s disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results